Table 4. Provider-reported vaccination status: Multivariable associations with scale and factor score means (n = 9,354).
| Scale | Factors | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Vaccinated | Confidence (8 items) | Benefits (4 items) | Harms (2 items) | Trust (2 items) | |||||
| n | OR | OR | OR | OR | |||||
| (%) | Mean (SE) | (95% CI) | Mean (SE) | (95% CI) | Mean (SE) | (95% CI) | Mean (SE) | (95% CI) | |
| Combined seriesa | |||||||||
| Yes | 7,122 | 1.35 | 1.16 | 0.93 | 1.08 | ||||
| (74%) | 8.47 (0.03) | (1.27, 1.44) | 8.88 (0.03) | (1.09, 1.23) | 3.32 (0.06) | (0.90, 0.96) | 9.43 (0.03) | (1.01, 1.17) | |
| No | 2,232 | ||||||||
| (26%) | 7.85 (0.06) | Reference | 8.31 (0.06) | Reference | 4.25 (0.11) | Reference | 9.05 (0.06) | Reference | |
| MMR | |||||||||
| Yes | 8,625 | 1.53 | 1.33 | 0.92 | 1.04 | ||||
| (91%) | 8.40 (0.02) | (1.40, 1.68) | 8.83 (0.03) | (1.23, 1.44) | 3.45 (0.05) | (0.86, 0.98) | 9.38 (0.03) | (0.94, 1.14) | |
| No | 729 | ||||||||
| (9%) | 7.39 (0.14) | Reference | 7.75 (0.13) | Reference | 4.79 (0.25) | Reference | 8.84 (0.12) | Reference | |
| Varicella | |||||||||
| Yes | 8,512 | 1.54 | 1.29 | 0.89 | 1.02 | ||||
| (91%) | 8.40 (0.02) | (1.42, 1.66) | 8.83 (0.03) | (1.19, 1.39) | 3.42 (0.05) | (0.84, 0.93) | 9.37 (0.03) | (0.93, 1.12) | |
| No | 842 | ||||||||
| (9%) | 7.39 (0.11) | Reference | 7.81 (0.12) | Reference | 4.97 (0.18) | Reference | 8.90 (0.09) | Reference | |
| Flu | |||||||||
| Yes | 3,400 | 1.32 | 1.13 | 0.92 | 1.06 | ||||
| (35%) | 8.56 (0.04) | (1.23, 1.42) | 8.97 (0.04) | (1.05, 1.22) | 3.18 (0.07) | (0.89, 0.96) | 9.48 (0.04) | (0.96, 1.17) | |
| No | 2,756 | ||||||||
| (33%) | 8.03 (0.05) | Reference | 8.50 (0.05) | Reference | 4.04 (0.10) | Reference | 9.17 (0.06) | Reference | |
| Not eligibleb | 3,198 | ||||||||
| (32%) | 8.32 (0.04) | 8.72 (0.04) | 3.50 (0.09) | 9.33 (0.05) | |||||
Note: CI: confidence interval. MMR: measles, mumps, and rubella. OR: odds ratio. SE: standard error. Table shows raw frequencies and weighted estimates. Models controlled for child’s race/ethnicity, mother’s educational attainment, and annual household income. Bolded odds ratios indicate statistically significant associations.
a Combined series (4:3:1:-:3:1:4) included ≥4 doses of DTaP/DT/DTP, ≥3 doses of poliovirus vaccine, ≥1 dose of measles-containing vaccine, ≥3 doses of HepB, ≥1 dose of varicella vaccine, and ≥4 doses of PCV. Hib excluded due to shortage.
b Not eligible group excluded from logistic regression models. This group consisted of children who were not 6- to 23- months of age for September 1 through December 31 in the year prior to data collection.